Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis
NCT03145428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2019-11-22
Summary
The measurement of monocyte volume width distribution (MDW) is intended for use with adult patients presenting to the emergency department (ED), where a CBC with Differential has been ordered, as an aid in the early detection of patients with or developing sepsis. The study will establish the clinical performance of MDW for detection of sepsis in the ED.
Conditions
- Sepsis
- Severe Infection
Interventions
- DIAGNOSTIC_TEST
-
CBC-Diff Monocyte volume width distribution (MDW)
MDW measurement used to detect sepsis. Results will not be used to manage patients
Sponsors & Collaborators
-
Beckman Coulter, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-19
- Primary Completion
- 2017-12-22
- Completion
- 2018-01-26
Countries
- United States
Study Locations
More Related Trials
-
Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University Hospital
NCT04819035 ·Status: COMPLETED
-
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
NCT04804306 ·Status: COMPLETED
-
Sepsis Prediction by Monocyte Distribution Width and Procalcitonin
NCT04322942 ·Status: UNKNOWN
-
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
NCT05296590 ·Status: ACTIVE_NOT_RECRUITING
-
Monocyte Distribution Width (MDW): An Early Marker of Sepsis in Patients With Comorbidities
NCT06953154 ·Status: COMPLETED
-
Feasibility Study of Hematology Parameters in COVID-19 Disease
NCT04816630 ·Status: COMPLETED
-
Possible Roles of MDW in Infection Management in Emergency Care
NCT04448548 ·Status: COMPLETED
-
Monocyte Distribution Width (MDW) in Hospital Practice
NCT04300530 ·Status: UNKNOWN
-
Leukocyte MOrphology and CORticosteroids Response in SEPtic Patients (MOCORSEP)
NCT04292431 ·Status: COMPLETED
-
Red Cell Distribution Width Versus Presepsin (Soluble CD14) as a Prognostic Marker in Critically-ill Sepsis Patients
NCT03796715 ·Status: COMPLETED
-
Study of Subcutaneous Interstitial Pressure During Sepsis
NCT03818269 ·Status: COMPLETED ·Phase: NA
-
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813 ·Status: UNKNOWN
-
Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock
NCT05921825 ·Status: UNKNOWN
-
Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis
NCT04103281 ·Status: RECRUITING
-
Early Prediction of Sepsis
NCT04570618 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of Red Cell Distribution Width (RDW) in Neonatal Sepsis
NCT03403062 ·Status: UNKNOWN
-
Quantification of Dilutional Anemia in the Initial Phase of Sepsis Management: Preliminary Retrospective Study
NCT06242561 ·Status: COMPLETED
-
Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)
NCT02232750 ·Status: COMPLETED
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
NCT06219135 ·Status: RECRUITING
-
C-reactive Protein Information and Blood Cultures for Emergency Department Patients With Sepsis
NCT03714841 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis
NCT01995448 ·Status: COMPLETED
-
Neutrophil Phenotypic Profiling and Organ Injury Assessment in Patients With Sepsis
NCT04103268 ·Status: RECRUITING
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
EVALUATION OF NEUTROPHIL FLUORESCENCE IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH SEPTIC SHOCK
NCT07039487 ·Status: NOT_YET_RECRUITING